Answers are grounded in this paper and cite their sources.
Randomized trial evaluates Gushukang's impact on bone density in women, suggesting enhanced outcomes with combination therapy.
Both Gushukang and menopausal hormone therapy for 6 months can increase BMD in perimenopausal and postmenopausal women; however, combination therapy yields superior results.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: